The Analyst Verdict: IGM Biosciences In The Eyes Of 5 Experts
The Analyst Verdict: IGM Biosciences In The Eyes Of 5 Experts
分析師的觀點：igm biosciences在5位專家眼中
Ratings for IGM Biosciences (NASDAQ:IGMS) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在過去的三個月中，IGm Biosciences (納斯達克股票代碼: IGMS)的評級來自5位分析師，展示了看好和看淡的觀點。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
總結他們最近的評估，下表展示了過去30天內不斷變化的情緒，並將其與之前的幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $18.4, a high estimate of $25.00, and a low estimate of $11.00. This upward trend is apparent, with the current average reflecting a 4.55% increase from the previous average price target of $17.60.
The 12-month price targets, analyzed by analysts, offer insights with an average target of $18.4, a high estimate of $25.00, and a low estimate of $11.00. This upward trend is apparent, with the current average reflecting a 4.55% increase from the previous average price target of $17.60.
Decoding Analyst Ratings: A Detailed Look
分析師評級解讀：詳細解析
An in-depth analysis of recent analyst...
最近對IGm生...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。